Resources

COVID-19 Testing – Evidence and Best Practices

Product: — Evidence Synthesis Network

Serological Testing Signs & Symptoms Testing & Tracing

esnetwork.ca Last Updated: June 25, 2020

Gabapentin, Phenobarbital, Diazepam, and Lorazepam for the Treatment of Alcohol Withdrawal: Clinical Effectiveness and Guidelines

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: June 23, 2020

Also available in Français

Use of Contact Tracing Apps to Contain COVID-19

Product: — Canadian Agency for Drugs and Technologies in Health

Testing & Tracing Tracing

covid.cadth.ca Last Updated: May 29, 2020

Also available in Français

Incremental Benefit of Using a History of Sudden Loss of Taste (Ageusia) And/Or Smell (Anosmia) in Symptom Screening for COVID-19

Product: — Evidence Synthesis Network

Less Common Signs & Symptoms Signs & Symptoms Testing & Tracing Tracing

esnetwork.ca Last Updated: May 28, 2020

Methoxyflurane for Acute Pain: Clinical Effectiveness

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: May 25, 2020

Also available in Français

Screening Approaches to Use in Non-Healthcare Settings to Identify People Who May Have COVID‑19 and Need To Take Appropriate Action

Product: — Evidence Synthesis Network

Community Prevention & Transmission Public Prevention Testing & Tracing Tracing

esnetwork.ca Last Updated: May 15, 2020